AMPH
Amphastar Pharmaceuticals Inc. (AMPH)
NASDAQ · Healthcare
Amphastar Pharmaceuticals Inc. annual/quarterly shareholder equity history from 2013 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Amphastar Pharmaceuticals Inc. shareholder equity for the quarter ending December 31, 2025 were 788.8M, a 7.72% increase year-over-year.
- Amphastar Pharmaceuticals Inc. shareholder equity for 2025 were 788.8M, a 7.72% increase from 2024.
- Amphastar Pharmaceuticals Inc. shareholder equity for 2024 were 732.3M, a 14.53% increase from 2023.
- Amphastar Pharmaceuticals Inc. shareholder equity for 2023 were 639.4M, a 20.95% increase from 2022.
- Amphastar Pharmaceuticals Inc. shareholder equity for 2022 were 528.7M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Amphastar Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $789 |
| 2024 | $732 |
| 2023 | $639 |
| 2022 | $529 |
| 2021 | $446 |
| 2020 | $402 |
| 2019 | $381 |
| 2018 | $332 |
| 2017 | $334 |
| 2016 | $329 |
| 2015 | $296 |
| 2014 | $282 |
| 2013 | $252 |
| Amphastar Pharmaceuticals Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $789 |
| 2024-12-31 | $732 |
| 2023-12-31 | $639 |
| 2022-12-31 | $529 |
| 2021-12-31 | $446 |
| 2020-12-31 | $402 |
| 2019-12-31 | $381 |
| 2018-12-31 | $332 |
| 2017-12-31 | $334 |
| 2016-12-31 | $329 |
| 2015-12-31 | $296 |
| 2014-12-31 | $282 |
| 2013-12-31 | $252 |
Amphastar Pharmaceuticals Inc. Shareholder Equity — FAQ
Amphastar Pharmaceuticals Inc. (AMPH) shareholder equity over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMPH's shareholder equity history?
The chart and table above show Amphastar Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.